Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Medicamen IPO
Medicamen Organics Ltd
₹1,28,000 /4000 sharesMinimum Investment
Medicamen IPO Details
| Bidding Dates | Min. Investment | Lot Size | Price Range |
|---|---|---|---|
| 21 Jun ‘24 - 25 Jun ‘24 | ₹1,28,000 | 4,000 | ₹32 - ₹34 |
| Issue Size | IPO Doc |
|---|---|
| 10.54Cr | RHP PDF |
About Medicamen
Founded in
1995
Managing director
Mr. Bal Kishan Gupta
Parent organisation
Medicamen Organics Ltd
Strengths & Financials of Medicamen
Strengths
Risks
Medicamen Organics holds ISO 9001:2015 certification for quality management systems.
As of September 30, 2023, the company's product range includes 84 products marketed globally under various brand names.
Medicamen Organics has a presence in India and overseas. It also holds approvals for product manufacturing in international markets. This includes countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, the Philippines, Myanmar, Mozambique, Burundi, Kyrgyzstan, and Kenya.
The company’s manufacturing facilities in Ranipur, Haridwar, hold WHO GMP approval.
Medicamen Organics depends on a few customers. Its top 10 customers accounted for 68.67%, 62.00%, 66.45%, and 55.82% of total sales for the six months ending September 30, 2023, and for the years ending March 31, 2023, 2022, and 2021, respectively. Any decline in quality, increased competition, or shift in demand could negatively impact the company.
The company relies heavily on a few key suppliers, with the top 10 suppliers contributing 47.48%, 61.25%, 38.71%, and 32.10% of total purchases for the six months ending September 30, 2023, and for the fiscal years ending March 31, 2023, 2022, and 2021, respectively. Losing any of these major suppliers could disrupt the company’s business operations.
As of September 30, 2023, Medicamen Organics had outstanding secured loans worth Rs 5.84 crore. Inability to service this debt could negatively affect the company.
The company’s directors and promoters are involved in legal proceedings. There are 10 criminal cases against the company, involving a total of Rs 0.16 crore, and 15 tax-related cases involving a total of Rs 1.89 crore. Any adverse judgments in these cases could hurt the company’s business
Medicamen Financials
*All values are in Rs. Cr
No Graph Data To Display
Application Details of Medicamen IPO
| Apply as | Price band | Apply Range |
|---|---|---|
| Regular | ₹32 - 34 | ₹2 - 5 Lakh |
| High Networth Individual | ₹32 - 34 | ₹2 - 5 Lakh |
For Medicamen IPO, eligible investors can apply as Regular.